Recce pharmaceuticals secures $8m placement and launches $3m entitlement offer to shareholders

Sydney, australia, sept. 13, 2023 (globe newswire) -- recce pharmaceuticals ltd (asx: rce, fse: r9q) (the company or recce), the company developing a new class of synthetic anti-infectives, announced today a capital raise of up to approximately $11 million before costs consisting of:
MMM Ratings Summary
MMM Quant Ranking